← All organizations

Heptares Therapeutics Limited

For profit

Also known as: Heptares Therapeutics Limited | Heptares Therapeutics Ltd | Heptares Therapeutics Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jul 13, 2023

Acquired by Sosei on Feb 22, 2015

Timeline

2000s

Jun 1, 2007
Heptares Therapeutics Limited— Founded

2010s

Feb 22, 2015
Sosei— Acquired By
Nov 29, 2016
G7 Therapeutics— Acquired

Drugs by trial phase (9 distinct, 15 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (6 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

G7 Therapeutics

Recent trials (17)

NCT05944237CollaboratorPhase 1/Phase 2Jul 13, 2023
NCT04935320Lead sponsorPhase 1Jul 27, 2021
NCT04941989Lead sponsorPhase 1Jun 30, 2021
NCT04462263Lead sponsorPhase 1Jun 29, 2020
NCT03847207Lead sponsorPhase 1Feb 13, 2019
NCT03785054Study directorPhase 1Nov 14, 2018
NCT03785054Lead sponsorPhase 1Nov 14, 2018
NCT03592862Lead sponsorPhase 2Sep 30, 2018
NCT03592862Study chairPhase 2Sep 30, 2018
NCT04849286Lead sponsorPhase 1Sep 26, 2018
NCT03456349Lead sponsorPhase 1Nov 10, 2017
NCT03244228Lead sponsorPhase 1Aug 25, 2017
NCT03198624Lead sponsorPhase 1May 16, 2017
NCT02958696Lead sponsorPhase 1Oct 1, 2016
NCT02710188Lead sponsorPhase 1Feb 1, 2016

Details

Founded: Welwyn Garden City, GB Jun 1, 2007
Last known activity: Jul 13, 2023